ClinicalTrials.Veeva

Menu

Expectations and Beliefs of Transgender People Regarding Hormonal Treatment

C

Central Hospital, Nancy, France

Status

Enrolling

Conditions

Transgenderism

Treatments

Other: no intervention

Study type

Observational

Funder types

Other

Identifiers

NCT05474768
2021PI221

Details and patient eligibility

About

Hormonal treatment of gender dysphoria can have repercussions on metabolism, cardiovascular system and fertility and represents à potential oncological risk. According to the recommendations of the Endocrine society. Therefore, initial assessment and follow-up visits are necessary and must be carried out to avoid the apparition of potentially undesirable effects.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • being a parent of adolescent/child presenting Gender dysphoria
  • adult subject (age > 18 years) presenting Gender dysphoria

non-inclusion criteria

  • Severe, uncontrolled psychiatric or somatic illness
  • Chronic alcoholism
  • Substance abuse
  • Refusal or linguistic, physical or psychological incapacity to participate in the study
  • Ongoing pregnancy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems